Gelonghui September 25th | Nuotai Biology (688076.SH) announced that the company recently received the State Food and Drug Administration approved and issued the "Drug Registration Certificate" (Certificate No.: 2024S02238) for the oseltamivir phosphate granules suspension. Oseltamivir phosphate granules suspension is a pharmaceutical against influenza virus, mainly used for the treatment of type A and type B influenza in patients aged 2 weeks and above, as well as for the prevention of type A and type B influenza in persons aged 1 year and above.
诺泰生物(688076.SH)：磷酸奥司他韦干混悬剂获得药品注册证书
Northeast Pharmaceutical (688076.SH): Oseltamivir phosphate granules for suspension obtained pharmaceutical registration certificate.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated